Video

Improving Treatment for Pediatric Cardiomyopathy

Author(s):

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Rakesh Singh, MD, MS, discussed some of these new developments in treatment during the 2014 American Heart Association Scientific Sessions in Chicago.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.